Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer: Final results of the NIFE-trial (AIO-YMO HEP-0315), a randomized phase II study of the AIO biliary tract cancer group

被引：15

作者：

Perkhofer, L. ^{[1
]}

Striefler, J. K. ^{[2
]}

Sinn, M. ^{[3
]}

Opitz, B. ^{[4
]}

Goetze, T. O. ^{[5
]}

Gallmeier, E. ^{[6
]}

von Weikersthal, L. Fischer ^{[7
]}

Jacobasch, L. ^{[8
]}

Waldschmidt, D. ^{[9
]}

Niedermeier, M. ^{[10
]}

Sohm, M. ^{[11
]}

Sookthai, D. ^{[5
]}

Berger, A. ^{[1
]}

Beutel, A. ^{[1
]}

Seufferlein, T. ^{[1
]}

Ettrich, T. J. ^{[1
]}

机构：

[1] Univ Ulm, Dept Internal Med, Ulm, Germany

[2] Charite Univmed Berlin, Hematol, Oncol & Tumor Immunol, Berlin, Germany

[3] UKE Univ Hamburg Eppendorf KMTZ, Dept Oncol Hematol & BMT Div Pneumol, Hamburg, Germany

[4] Hosp St Elisabeth & St Barbara Halle, Med Oncol, Halle, Germany

[5] UCT Univ, Inst Clin Canc Res IKF Krankenhaus Nordwe, Canc Ctr, Frankfurt, Germany

[6] Philipps Univ Marburg, Dept Gastroenterol & Endocrinol, Marburg, Germany

[7] Praxis Dr L Fischer W Klinikum St Marien Amberg, Amberg, Germany

[8] Oncol Heamatol Det, Gemeinschaftspraxis Haematol Onkol, Dresden, Germany

[9] Univ Koln AoR, Klin Gastroenterol & Hepatol, Cologne, Germany

[10] Oncol Heamatol, Private Practice Memmingen, Memmingen, Germany

[11] SAPV Praxis Dr Vehling Kaiser, Landshut, Germany

来源：

关键词：

D O I：

10.1016/j.annonc.2021.08.2082

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA10

引用

页码：S1282 / S1282

页数：1